Invention Grant
- Patent Title: Anti-angiogenic therapy
- Patent Title (中): 抗血管生成治疗
-
Application No.: US14170997Application Date: 2014-02-03
-
Publication No.: US09085617B2Publication Date: 2015-07-21
- Inventor: Jean-Marie Stassen , Peter Carmeliet , Desire Collen
- Applicant: VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW , LIFE SCIENCES RESEARCH PARTNERS VZW , THROMBOGENICS N.V.
- Applicant Address: BE Leuven BE Zwijnaarde BE Leuven
- Assignee: THROMBOGENICS N.V.,VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW,LIFE SCIENCES RESEARCH PARTNERS VZW
- Current Assignee: THROMBOGENICS N.V.,VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW,LIFE SCIENCES RESEARCH PARTNERS VZW
- Current Assignee Address: BE Leuven BE Zwijnaarde BE Leuven
- Agency: Nixon & Vanderhye P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22 ; A61K45/06 ; A61K39/00
Abstract:
The present invention provides novel monoclonal antibodies directed to PlGF and fragments and derivatives thereof, more particularly to humanized antibodies and fragments thereof for use in the treatment and/or prevention of pathological angiogenesis.
Public/Granted literature
- US20140178397A1 ANTI-ANGIOGENIC THERAPY Public/Granted day:2014-06-26
Information query
